Neurocrine Biosciences 1 article

One scientific anchor for Neurocrine Biosciences is neuroscience therapeutics, and another is vesicular monoamine transporter 2 targeting; together they define its role as a biopharmaceutical company. In Neurocrine Biosciences, endocrine disorder therapeutics connects with CRF1 receptor antagonism; the role of neurotransmitter pathway modulation helps distinguish the therapeutic strategy from neighboring biopharma entities. Products and pathways are mapped separately from Neurocrine Biosciences; neuroscience and endocrine drug discovery remains part of the organization's durable scientific profile.